HomeAboutSolutionsHow we workCareersContactRegulatory tool

Clinical supply,
simplified.

Comparator sourcing, GMP packaging and labelling, QP release and temperature controlled delivery — coordinated end to end from Switzerland and the Netherlands.

Discuss your studySee our solutions
CH / NLOperating bases
GDP / WDAAligned end to end
24 hSourcing feedback
About

Built for agility. Driven by purpose. Trusted for quality.

Cure Pharma was founded to bring simplicity, reliability and speed to clinical supply. We saw fragmented supply models holding studies back and built a connected alternative, backed by regulatory expertise and global execution.

Our story

Our founding team came from inside the industry with hands-on experience in managing pharmaceutical supply chains: managing global supply chains, sourcing rare comparators, navigating regulatory complexity. We knew the pain points first-hand — rigid vendors, unclear accountability and delays that cost time and money. Cure Pharma exists to remove them.

Our team

Leadership and operations combine pharmaceutical, clinical supply, regulatory and logistics experience. A flat structure and lean processes mean quick decisions, consistent communication and personal accountability. We are hands-on, reachable and we deliver what we promise.

  • Leadership

    Industry veterans with deep pharmaceutical and supply chain expertise.

  • Quality

    Specialists in regulatory compliance and quality assurance.

  • Operations

    Experts in global logistics and clinical supply coordination.

Solutions

Our solutions

Tailored support at every stage of the clinical supply chain.

Clinical supply management

One team from sourcing to QP release.

We manage sourcing, transport, storage and release as one integrated process, with a single point of contact who owns the schedule. Whether you want us to manage your clinical supplies or only require selected services, our team is here to help.

What you gain
  • One contact accountable for every vendor and milestone
  • Proactive risk and exception management
  • A setup that flexes from modular to full service

Comparator sourcing

Originators, generics and biosimilars, found and documented.

Our global network reaches the markets where your comparator actually sits, including hard-to-find products. Every supply arrives with the paperwork your QA team will ask for.

What you gain
  • Batch-specific sourcing with full traceability
  • Complete documentation, including CoA and CoC
  • Feedback on availability within 24 hours

Packaging & labelling

Kits that match the protocol and the country.

From relabelling market packs to building custom clinical kits with multilingual booklet labels. Primary and secondary packaging, blinding and randomisation, all under GMP.

What you gain
  • GMP primary and secondary packaging
  • Country-compliant multilingual labels
  • Blinded randomisation

QP release & regulatory

Release without delay. Compliance without doubt.

EU QP release coordinated against your study timeline, with audit-ready documentation from the first shipment. We work only with qualified partners and keep the file complete as the study changes.

What you gain
  • QP release scheduled around first-patient-in
  • Swissmedic and EU alignment across markets
  • Audit-ready files kept current, not reconstructed

Logistics & depot management

Frozen, cold and ambient — tracked to the last mile.

Validated temperature-controlled shipping, depot storage close to your sites, and full reverse logistics. We collect and destroy unused or expired products with documentation you need.

What you gain
  • Handling at −80 °C, −20 °C, 2–8 °C and 15–25 °C
  • Inventory visibility by location, batch and expiry
  • Returns and destruction, fully documented

Global Access Programs

Expanding access to life-saving therapies worldwide through Named Patient Programs (NPP), Post-Trial Programs, and urgent hospital supplies.

We bridge critical access gaps by facilitating ethical, compliant pathways for named patient-treatments, Post-Trial Programs, unregistered innovative therapies, and essential medicines facing critical market shortages.

Whether managing global Named Patient Programs (NPP), Post-Trial Programs or sourcing emergency unlicensed supplies for hospitals and clinics, we ensure full regulatory compliance, complete traceability, and validated temperature controlled deliveries.

What you gain
  • Fully compliant Named Patient Program (NPP) & Post-Trial Managed Access execution
  • Global sourcing for unlicensed, hard-to-find, and shortage medicines
  • Rapid, GDP-compliant global sourcing of critical commercial medicines, ensuring continuous patient care in hospital and clinical settings.
  • Validated, temperature-controlled last-mile delivery directly to hospitals.

Regulatory toolBETA

AI Clinical Supply Regulatory Advisory

Do not gamble with your trial execution. Understand beforehand your comparators and IMP regulatory needs, mitigating bureaucracy delays and protecting your trial timelines. We help you understand in advance the regulatory framework behind your clinical projects, with an AI-powered tool built by Cure Pharma.

What you gain
  • The governing health authority for any origin–destination route
  • What the destination country requires for import
  • Free to use, for preliminary planning; verify with your QP or local partner
Open the regulatory tool (opens in a new tab)
More than 80% of trials face sourcing delays. Ours don't.

Cure Pharma — comparator sourcing

How we work

Our process. Your peace of mind.

Every project starts with understanding the trial, not the shipment. We map your supply needs across availability, sourcing, storage, transport, QP release and packaging — then adapt as the study moves.

  • Partnership first

    Transparent timelines, solutions scaled to trial size and complexity, and a modular setup that steps in exactly where you need it.

  • One point of contact

    Vendor coordination, shipment and release scheduling, status reporting, escalations and change requests — handled by one named person.

  • Quality and compliance

    GDP and GMP standards across services, a qualified vendor network, and traceable, audit-ready documentation by design.

  • Supply chain visibility

    Shipment and release status, inventory by location, batch and expiry, plus escalation alerts before you have to ask.

Customer stories

When the timeline matters

Real-world examples of how regulatory judgment, direct sourcing and disciplined logistics keep clinical programs moving.

Case Study:01

Rescuing Study Timelines After a Third-Party Import Failure

At a Glance

  • Challenge: Impending study delay due to missing import documentation from a third-party vendor
  • Service: Regulatory Intelligence & Health Authority Liaison
  • Impact: 100% compliant border clearance with zero delay to First Patient In (FPI)
The Challenge

A clinical-stage sponsor was preparing to launch a trial in an Eastern-European country using a US-marketed comparator sourced via an external vendor. Just prior to import, the sponsor's CRO flagged that the destination country required specialized quality documentation that the sourcing vendor was unable to obtain. With the supply chain stalled, site initiation and the trial's scheduled start were at immediate risk of a multi-week postponement.

The Intervention

Although Cure Pharma was not the supplier for the comparator, the sponsor approached our team for rapid regulatory guidance:

  • Regulatory Pathway Assessment: Our regulatory specialists audited local import regulations, identifying specific legal exemptions where import was permissible without the contested paperwork.
  • Direct Stakeholder Alignment: We facilitated precise, transparent communication between the sponsor, national health authorities, and customs officials to confirm the alternative compliance route.
  • Risk Mitigation: Provided the CRO and sponsor quality teams with documented authority confirmation to ensure audit readiness and remove inspection risk.
The Outcome
  • Preserved Study Timeline: The comparator cleared customs compliantly without requiring the missing vendor documents, keeping the scheduled First Patient In exactly on track.
  • Zero Sunk Costs: Prevented the need to scrap and re-source the US comparator batch, saving significant capital and months of procurement lead time.
  • Ongoing Partnership: Demonstrated end-to-end problem solving that led the sponsor to transition future sourcing and regulatory release activities directly to Cure Pharma.
Case Study:02

Multi-Batch Sourcing & Cold-Chain Consolidation for an Oncology Reference Drug

At a Glance

  • Therapeutic Area & Profile: Oncology Reference Drug (+2°C to +8°C Cold Chain)
  • Challenge: Sourcing multiple batches with specific expiries under urgent analytical timelines
  • Service: Direct Manufacturer Sourcing & GDP Cold-Chain Depot Consolidation
  • Impact: Reduced lead time by >50%, eliminated excursion risks, and reduced shipping costs via single shipment dispatch
The Challenge

An analytical research team required multiple batches of an oncology reference drug with staggered expiration dates to conduct comparative characterization testing. Beyond the difficulty of obtaining diverse lot numbers through traditional wholesalers, the product was strictly temperature-sensitive (+2°C to +8°C). Competing vendors quoted multi-month lead times and proposed fragmented, lot-by-lot dispatches, which multiplied the risks of temperature excursions, complicated laboratory receiving workflows, and generated excessive cold-chain freight charges.

The Intervention

Cure Pharma leveraged its direct supply network and centralized European infrastructure to execute a streamlined sourcing and handling strategy:

  • Direct Manufacturer Allocation: Bypassed open-market options to secure the complete matrix of required oncology batches and expiry profiles directly from the manufacturer.
  • GDP Cold-Chain Depot Ingestion: Received and stored the lots within a validated +2°C to +8°C storage environment at a Cure Pharma depot.
  • Single Temperature-Controlled Dispatch: Consolidated all batches into a single qualified +2°C to +8°C shipping solution equipped with temperature loggers, delivering all batches to the laboratory in a single coordinated drop.
The Outcome
  • Procurement Time Cut by >50%: Sourced and delivered the full set of batches in less than half the time estimated by conventional vendors, keeping the sponsor's testing program on schedule.
  • Logistics Costs Minimized: Replacing multiple individual cold-chain dispatches with one consolidated shipment sharply reduced logistics costs.
  • Thermal & Regulatory Integrity: Maintained an unbroken +2°C to +8°C profile across the entire custody chain, backed by complete batch documentation, and temperature logs ready for regulatory inspection.
Cold chain

Held to the degree

Frozen, refrigerated and ambient product handled in validated conditions, with a documented temperature record from depot to site.

Frozen−80 °C and −20 °C

Biologics and investigational product requiring deep freeze.

−80
−60
−40
−20
0
20

Refrigerated2–8 °C

The standard cold chain for most comparator and reference products.

−80
−60
−40
−20
0
20

Controlled ambient15–25 °C

Room-temperature product kept inside its validated range, not just indoors.

−80
−60
−40
−20
0
20
Careers

Work where decisions are quick

We are small, flat and hands-on. If you have worked in clinical supply, QA or logistics and want fewer layers between you and the work, we would like to hear from you.

  • Clinical Supply Project ManagerRotkreuz, CH | Remote, EU
  • Senior Business Development, Clinical SupplyRemote, EU
  • Supply Chain ManagerRotkreuz, CH | Remote, EU
  • Sourcing Associate, comparatorsRemote, EU

No matching role open? Send an open application. We read everything and answer within two weeks.

Send an application

Contact

Let's simplify your clinical supply chain

Tell us about the study phase, countries, timelines and we will come back with a concrete plan, not a brochure.

Switzerland / NetherlandsContact us
Switzerland
Cure Pharma (Switzerland) GmbH
Suurstoffi 12b
6343 Rotkreuz
Netherlands
Cure Pharma (Netherlands) B.V.
Posthoornstraat 11
3011WD Rotterdam